The role of Vitamin D3 in ocular fibrosis and its therapeutic potential for the glaucomatous trabecular meshwork Article Swipe
Alexander Morelli-Batters
,
Hannah C. Lamont
,
Mirna Elghobashy
,
Imran Masood
,
Lisa J. Hill
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.3389/fopht.2022.897118
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.3389/fopht.2022.897118
Glaucoma is the leading cause of irreversible blindness globally. The most prevalent subtype, Primary Open Angle Glaucoma (POAG), is characterized by increased intraocular pressure (IOP), damage to the optic nerve head and irreversible visual loss. IOP increases aqueous humor (AqH) outflow is reduced through the trabecular meshwork (TM) and Schlemm’s canal (SC). Increased outflow resistance is partly due to TM/SC dysregulation, including loss of normal trabecular meshwork cell (TMC) function, following increased levels of oxidative stress within TMC, dysregulated extracellular matrix (ECM) deposition and remodeling alongside alterations in TMC phenotype and apoptosis. Current widely available POAG treatments do not target the aberrant expression of ECM in the TM directly. As a result, most drug treatments can fail as the underlying pathological process continues unabated. Rho-kinase inhibitors have demonstrated the benefit of restoring TM/SC function, however there is a clear need to develop further treatment strategies that can target the underlying cellular processes which become dysregulated within the TMC during POAG pathogenesis. Vitamin D is suggested to be beneficial in alleviating the symptoms of fibrosis and inflammation in soft tissues. It has important functions in many major organ systems, including regulation of calcium, phosphate and parathyroid hormone. Evidence suggests that Vitamin D3 modulates ECM turnover through the conventional TGFβ-SMAD signaling, which is associated with the development of POAG. The link between Vitamin D3, inflammation and fibrosis within ocular tissues will be discussed and the potential roles of Vitamin D3 in the management of POAG patients will be explored within this review.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fopht.2022.897118
- https://www.frontiersin.org/articles/10.3389/fopht.2022.897118/pdf
- OA Status
- diamond
- Cited By
- 3
- References
- 95
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4289170425
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4289170425Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fopht.2022.897118Digital Object Identifier
- Title
-
The role of Vitamin D3 in ocular fibrosis and its therapeutic potential for the glaucomatous trabecular meshworkWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-08-01Full publication date if available
- Authors
-
Alexander Morelli-Batters, Hannah C. Lamont, Mirna Elghobashy, Imran Masood, Lisa J. HillList of authors in order
- Landing page
-
https://doi.org/10.3389/fopht.2022.897118Publisher landing page
- PDF URL
-
https://www.frontiersin.org/articles/10.3389/fopht.2022.897118/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/articles/10.3389/fopht.2022.897118/pdfDirect OA link when available
- Concepts
-
Trabecular meshwork, Glaucoma, Medicine, Fibrosis, Intraocular pressure, Ocular hypertension, CTGF, Ophthalmology, Endocrinology, Internal medicine, Growth factor, ReceptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
95Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4289170425 |
|---|---|
| doi | https://doi.org/10.3389/fopht.2022.897118 |
| ids.doi | https://doi.org/10.3389/fopht.2022.897118 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38983544 |
| ids.openalex | https://openalex.org/W4289170425 |
| fwci | 0.84471231 |
| type | article |
| title | The role of Vitamin D3 in ocular fibrosis and its therapeutic potential for the glaucomatous trabecular meshwork |
| biblio.issue | |
| biblio.volume | 2 |
| biblio.last_page | 897118 |
| biblio.first_page | 897118 |
| topics[0].id | https://openalex.org/T10250 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2731 |
| topics[0].subfield.display_name | Ophthalmology |
| topics[0].display_name | Glaucoma and retinal disorders |
| topics[1].id | https://openalex.org/T11538 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9994000196456909 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2734 |
| topics[1].subfield.display_name | Pathology and Forensic Medicine |
| topics[1].display_name | Ophthalmology and Eye Disorders |
| topics[2].id | https://openalex.org/T10170 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9968000054359436 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2731 |
| topics[2].subfield.display_name | Ophthalmology |
| topics[2].display_name | Retinal Diseases and Treatments |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2781121420 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9501366019248962 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q750873 |
| concepts[0].display_name | Trabecular meshwork |
| concepts[1].id | https://openalex.org/C2778527774 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7273757457733154 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q159701 |
| concepts[1].display_name | Glaucoma |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.5884972810745239 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2780559512 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5280992388725281 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q605709 |
| concepts[3].display_name | Fibrosis |
| concepts[4].id | https://openalex.org/C2781092963 |
| concepts[4].level | 2 |
| concepts[4].score | 0.49542272090911865 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q650050 |
| concepts[4].display_name | Intraocular pressure |
| concepts[5].id | https://openalex.org/C2776521421 |
| concepts[5].level | 3 |
| concepts[5].score | 0.44794654846191406 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q9294051 |
| concepts[5].display_name | Ocular hypertension |
| concepts[6].id | https://openalex.org/C2780631158 |
| concepts[6].level | 4 |
| concepts[6].score | 0.4110838770866394 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q14907752 |
| concepts[6].display_name | CTGF |
| concepts[7].id | https://openalex.org/C118487528 |
| concepts[7].level | 1 |
| concepts[7].score | 0.35064786672592163 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q161437 |
| concepts[7].display_name | Ophthalmology |
| concepts[8].id | https://openalex.org/C134018914 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3363611102104187 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[8].display_name | Endocrinology |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.315753698348999 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C2775960820 |
| concepts[10].level | 3 |
| concepts[10].score | 0.17408698797225952 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q408378 |
| concepts[10].display_name | Growth factor |
| concepts[11].id | https://openalex.org/C170493617 |
| concepts[11].level | 2 |
| concepts[11].score | 0.09159168601036072 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[11].display_name | Receptor |
| keywords[0].id | https://openalex.org/keywords/trabecular-meshwork |
| keywords[0].score | 0.9501366019248962 |
| keywords[0].display_name | Trabecular meshwork |
| keywords[1].id | https://openalex.org/keywords/glaucoma |
| keywords[1].score | 0.7273757457733154 |
| keywords[1].display_name | Glaucoma |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.5884972810745239 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/fibrosis |
| keywords[3].score | 0.5280992388725281 |
| keywords[3].display_name | Fibrosis |
| keywords[4].id | https://openalex.org/keywords/intraocular-pressure |
| keywords[4].score | 0.49542272090911865 |
| keywords[4].display_name | Intraocular pressure |
| keywords[5].id | https://openalex.org/keywords/ocular-hypertension |
| keywords[5].score | 0.44794654846191406 |
| keywords[5].display_name | Ocular hypertension |
| keywords[6].id | https://openalex.org/keywords/ctgf |
| keywords[6].score | 0.4110838770866394 |
| keywords[6].display_name | CTGF |
| keywords[7].id | https://openalex.org/keywords/ophthalmology |
| keywords[7].score | 0.35064786672592163 |
| keywords[7].display_name | Ophthalmology |
| keywords[8].id | https://openalex.org/keywords/endocrinology |
| keywords[8].score | 0.3363611102104187 |
| keywords[8].display_name | Endocrinology |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.315753698348999 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/growth-factor |
| keywords[10].score | 0.17408698797225952 |
| keywords[10].display_name | Growth factor |
| keywords[11].id | https://openalex.org/keywords/receptor |
| keywords[11].score | 0.09159168601036072 |
| keywords[11].display_name | Receptor |
| language | en |
| locations[0].id | doi:10.3389/fopht.2022.897118 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210204172 |
| locations[0].source.issn | 2674-0826 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2674-0826 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Ophthalmology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/articles/10.3389/fopht.2022.897118/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Ophthalmology |
| locations[0].landing_page_url | https://doi.org/10.3389/fopht.2022.897118 |
| locations[1].id | pmid:38983544 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in ophthalmology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38983544 |
| locations[2].id | pmh:oai:pure.atira.dk:publications/7f616f96-d84c-4536-8192-8301ea72aaf7 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400216 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Research Portal (King's College London) |
| locations[2].source.host_organization | https://openalex.org/I183935753 |
| locations[2].source.host_organization_name | King's College London |
| locations[2].source.host_organization_lineage | https://openalex.org/I183935753 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Morelli-batters , A , Lamont , H C , Elghobashy , M , Masood , I & Hill , L J 2022 , ' The role of Vitamin D3 in ocular fibrosis and its therapeutic potential for the glaucomatous trabecular meshwork ' , Frontiers in Ophthalmology , vol. 2 , 897118 . https://doi.org/10.3389/fopht.2022.897118 |
| locations[2].landing_page_url | https://birmingham.elsevierpure.com/en/publications/7f616f96-d84c-4536-8192-8301ea72aaf7 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11182265 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Front Ophthalmol (Lausanne) |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11182265 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5021231749 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Alexander Morelli-Batters |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I79619799 |
| authorships[0].affiliations[0].raw_affiliation_string | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom |
| authorships[0].institutions[0].id | https://openalex.org/I79619799 |
| authorships[0].institutions[0].ror | https://ror.org/03angcq70 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I79619799 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | University of Birmingham |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Alexander Morelli-Batters |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom |
| authorships[1].author.id | https://openalex.org/A5034308593 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-9588-3066 |
| authorships[1].author.display_name | Hannah C. Lamont |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I79619799 |
| authorships[1].affiliations[0].raw_affiliation_string | School of Chemical Engineering, Healthcare Technologies Institute, University of Birmingham, Birmingham, United Kingdom |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I79619799 |
| authorships[1].affiliations[1].raw_affiliation_string | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom |
| authorships[1].institutions[0].id | https://openalex.org/I79619799 |
| authorships[1].institutions[0].ror | https://ror.org/03angcq70 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I79619799 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | University of Birmingham |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Hannah C. Lamont |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom, School of Chemical Engineering, Healthcare Technologies Institute, University of Birmingham, Birmingham, United Kingdom |
| authorships[2].author.id | https://openalex.org/A5000018739 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3952-7366 |
| authorships[2].author.display_name | Mirna Elghobashy |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I79619799 |
| authorships[2].affiliations[0].raw_affiliation_string | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom |
| authorships[2].institutions[0].id | https://openalex.org/I79619799 |
| authorships[2].institutions[0].ror | https://ror.org/03angcq70 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I79619799 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | University of Birmingham |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mirna Elghobashy |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom |
| authorships[3].author.id | https://openalex.org/A5027081335 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2451-4108 |
| authorships[3].author.display_name | Imran Masood |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I79619799 |
| authorships[3].affiliations[0].raw_affiliation_string | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom |
| authorships[3].institutions[0].id | https://openalex.org/I79619799 |
| authorships[3].institutions[0].ror | https://ror.org/03angcq70 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I79619799 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | University of Birmingham |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Imran Masood |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom |
| authorships[4].author.id | https://openalex.org/A5082005077 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-8431-7029 |
| authorships[4].author.display_name | Lisa J. Hill |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I79619799 |
| authorships[4].affiliations[0].raw_affiliation_string | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom |
| authorships[4].institutions[0].id | https://openalex.org/I79619799 |
| authorships[4].institutions[0].ror | https://ror.org/03angcq70 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I79619799 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | University of Birmingham |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Lisa J. Hill |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/articles/10.3389/fopht.2022.897118/pdf |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | The role of Vitamin D3 in ocular fibrosis and its therapeutic potential for the glaucomatous trabecular meshwork |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10250 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2731 |
| primary_topic.subfield.display_name | Ophthalmology |
| primary_topic.display_name | Glaucoma and retinal disorders |
| related_works | https://openalex.org/W2407208342, https://openalex.org/W4213090044, https://openalex.org/W780712120, https://openalex.org/W2153282399, https://openalex.org/W4389793421, https://openalex.org/W23766661, https://openalex.org/W2886276864, https://openalex.org/W2061633192, https://openalex.org/W1992282721, https://openalex.org/W2910975531 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3389/fopht.2022.897118 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210204172 |
| best_oa_location.source.issn | 2674-0826 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2674-0826 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Ophthalmology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fopht.2022.897118/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Ophthalmology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fopht.2022.897118 |
| primary_location.id | doi:10.3389/fopht.2022.897118 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210204172 |
| primary_location.source.issn | 2674-0826 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2674-0826 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Ophthalmology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fopht.2022.897118/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Ophthalmology |
| primary_location.landing_page_url | https://doi.org/10.3389/fopht.2022.897118 |
| publication_date | 2022-08-01 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W3110220146, https://openalex.org/W2021933371, https://openalex.org/W3210139851, https://openalex.org/W2805716534, https://openalex.org/W2506683540, https://openalex.org/W2986040489, https://openalex.org/W2034742711, https://openalex.org/W2142309352, https://openalex.org/W2028326278, https://openalex.org/W1986864538, https://openalex.org/W2792649607, https://openalex.org/W2786964098, https://openalex.org/W2802168264, https://openalex.org/W2575513480, https://openalex.org/W3038496802, https://openalex.org/W2946297119, https://openalex.org/W6770667555, https://openalex.org/W2052911528, https://openalex.org/W1983259922, https://openalex.org/W2972542992, https://openalex.org/W4200377027, https://openalex.org/W2944783972, https://openalex.org/W3144890875, https://openalex.org/W2801669643, https://openalex.org/W1589883334, https://openalex.org/W6656626004, https://openalex.org/W2064186020, https://openalex.org/W2150683115, https://openalex.org/W2074298714, https://openalex.org/W2168966615, https://openalex.org/W3076052702, https://openalex.org/W3118951758, https://openalex.org/W3048680298, https://openalex.org/W2991640328, https://openalex.org/W3036298417, https://openalex.org/W3012820186, https://openalex.org/W3103084163, https://openalex.org/W2905700552, https://openalex.org/W3004714792, https://openalex.org/W2751043712, https://openalex.org/W2145489993, https://openalex.org/W3178049244, https://openalex.org/W2326486172, https://openalex.org/W3164766702, https://openalex.org/W3127957379, https://openalex.org/W2952322779, https://openalex.org/W3163261055, https://openalex.org/W2949752766, https://openalex.org/W2099842384, https://openalex.org/W2966231921, https://openalex.org/W2056951397, https://openalex.org/W3119108562, https://openalex.org/W3024365813, https://openalex.org/W3087906631, https://openalex.org/W2994646162, https://openalex.org/W2007992196, https://openalex.org/W2094535521, https://openalex.org/W2053837765, https://openalex.org/W3026105726, https://openalex.org/W2002817389, https://openalex.org/W2028243025, https://openalex.org/W2042130706, https://openalex.org/W2063924232, https://openalex.org/W3080525018, https://openalex.org/W3137299598, https://openalex.org/W1993066239, https://openalex.org/W2144378498, https://openalex.org/W2095432633, https://openalex.org/W2015494251, https://openalex.org/W2164530918, https://openalex.org/W2112903125, https://openalex.org/W1985434939, https://openalex.org/W2035122148, https://openalex.org/W2100570941, https://openalex.org/W2052337638, https://openalex.org/W2144781085, https://openalex.org/W2073740870, https://openalex.org/W1969076105, https://openalex.org/W2044099516, https://openalex.org/W1964335024, https://openalex.org/W2134427614, https://openalex.org/W2083347376, https://openalex.org/W2169282214, https://openalex.org/W2486665901, https://openalex.org/W2273834531, https://openalex.org/W3188003881, https://openalex.org/W2341403492, https://openalex.org/W2604797828, https://openalex.org/W2003966429, https://openalex.org/W3199386796, https://openalex.org/W2105963014, https://openalex.org/W3037972540, https://openalex.org/W2771780689, https://openalex.org/W2016279028, https://openalex.org/W2026103376 |
| referenced_works_count | 95 |
| abstract_inverted_index.D | 162 |
| abstract_inverted_index.a | 110, 137 |
| abstract_inverted_index.As | 109 |
| abstract_inverted_index.D3 | 200, 237 |
| abstract_inverted_index.It | 179 |
| abstract_inverted_index.TM | 107 |
| abstract_inverted_index.as | 117 |
| abstract_inverted_index.be | 166, 229, 245 |
| abstract_inverted_index.by | 20 |
| abstract_inverted_index.do | 97 |
| abstract_inverted_index.in | 87, 105, 168, 176, 183, 238 |
| abstract_inverted_index.is | 1, 18, 41, 55, 136, 163, 210 |
| abstract_inverted_index.of | 5, 63, 73, 103, 130, 172, 190, 215, 235, 241 |
| abstract_inverted_index.to | 26, 58, 140, 165 |
| abstract_inverted_index.D3, | 221 |
| abstract_inverted_index.ECM | 104, 202 |
| abstract_inverted_index.IOP | 35 |
| abstract_inverted_index.TMC | 88, 157 |
| abstract_inverted_index.The | 9, 217 |
| abstract_inverted_index.and | 31, 48, 83, 90, 174, 193, 223, 231 |
| abstract_inverted_index.can | 115, 146 |
| abstract_inverted_index.due | 57 |
| abstract_inverted_index.has | 180 |
| abstract_inverted_index.not | 98 |
| abstract_inverted_index.the | 2, 27, 44, 100, 106, 118, 128, 148, 156, 170, 205, 213, 232, 239 |
| abstract_inverted_index.(TM) | 47 |
| abstract_inverted_index.Open | 14 |
| abstract_inverted_index.POAG | 95, 159, 242 |
| abstract_inverted_index.TMC, | 77 |
| abstract_inverted_index.cell | 67 |
| abstract_inverted_index.drug | 113 |
| abstract_inverted_index.fail | 116 |
| abstract_inverted_index.have | 126 |
| abstract_inverted_index.head | 30 |
| abstract_inverted_index.link | 218 |
| abstract_inverted_index.loss | 62 |
| abstract_inverted_index.many | 184 |
| abstract_inverted_index.most | 10, 112 |
| abstract_inverted_index.need | 139 |
| abstract_inverted_index.soft | 177 |
| abstract_inverted_index.that | 145, 198 |
| abstract_inverted_index.this | 248 |
| abstract_inverted_index.will | 228, 244 |
| abstract_inverted_index.with | 212 |
| abstract_inverted_index.(AqH) | 39 |
| abstract_inverted_index.(ECM) | 81 |
| abstract_inverted_index.(SC). | 51 |
| abstract_inverted_index.(TMC) | 68 |
| abstract_inverted_index.Angle | 15 |
| abstract_inverted_index.POAG. | 216 |
| abstract_inverted_index.TM/SC | 59, 132 |
| abstract_inverted_index.canal | 50 |
| abstract_inverted_index.cause | 4 |
| abstract_inverted_index.clear | 138 |
| abstract_inverted_index.humor | 38 |
| abstract_inverted_index.loss. | 34 |
| abstract_inverted_index.major | 185 |
| abstract_inverted_index.nerve | 29 |
| abstract_inverted_index.optic | 28 |
| abstract_inverted_index.organ | 186 |
| abstract_inverted_index.roles | 234 |
| abstract_inverted_index.there | 135 |
| abstract_inverted_index.which | 152, 209 |
| abstract_inverted_index.(IOP), | 24 |
| abstract_inverted_index.become | 153 |
| abstract_inverted_index.damage | 25 |
| abstract_inverted_index.during | 158 |
| abstract_inverted_index.levels | 72 |
| abstract_inverted_index.matrix | 80 |
| abstract_inverted_index.normal | 64 |
| abstract_inverted_index.ocular | 226 |
| abstract_inverted_index.partly | 56 |
| abstract_inverted_index.stress | 75 |
| abstract_inverted_index.target | 99, 147 |
| abstract_inverted_index.visual | 33 |
| abstract_inverted_index.widely | 93 |
| abstract_inverted_index.within | 76, 155, 225, 247 |
| abstract_inverted_index.(POAG), | 17 |
| abstract_inverted_index.Current | 92 |
| abstract_inverted_index.Primary | 13 |
| abstract_inverted_index.Vitamin | 161, 199, 220, 236 |
| abstract_inverted_index.aqueous | 37 |
| abstract_inverted_index.benefit | 129 |
| abstract_inverted_index.between | 219 |
| abstract_inverted_index.develop | 141 |
| abstract_inverted_index.further | 142 |
| abstract_inverted_index.however | 134 |
| abstract_inverted_index.leading | 3 |
| abstract_inverted_index.outflow | 40, 53 |
| abstract_inverted_index.process | 121 |
| abstract_inverted_index.reduced | 42 |
| abstract_inverted_index.result, | 111 |
| abstract_inverted_index.review. | 249 |
| abstract_inverted_index.through | 43, 204 |
| abstract_inverted_index.tissues | 227 |
| abstract_inverted_index.Evidence | 196 |
| abstract_inverted_index.Glaucoma | 0, 16 |
| abstract_inverted_index.aberrant | 101 |
| abstract_inverted_index.calcium, | 191 |
| abstract_inverted_index.cellular | 150 |
| abstract_inverted_index.explored | 246 |
| abstract_inverted_index.fibrosis | 173, 224 |
| abstract_inverted_index.hormone. | 195 |
| abstract_inverted_index.meshwork | 46, 66 |
| abstract_inverted_index.patients | 243 |
| abstract_inverted_index.pressure | 23 |
| abstract_inverted_index.subtype, | 12 |
| abstract_inverted_index.suggests | 197 |
| abstract_inverted_index.symptoms | 171 |
| abstract_inverted_index.systems, | 187 |
| abstract_inverted_index.tissues. | 178 |
| abstract_inverted_index.turnover | 203 |
| abstract_inverted_index.Increased | 52 |
| abstract_inverted_index.alongside | 85 |
| abstract_inverted_index.available | 94 |
| abstract_inverted_index.blindness | 7 |
| abstract_inverted_index.continues | 122 |
| abstract_inverted_index.directly. | 108 |
| abstract_inverted_index.discussed | 230 |
| abstract_inverted_index.following | 70 |
| abstract_inverted_index.function, | 69, 133 |
| abstract_inverted_index.functions | 182 |
| abstract_inverted_index.globally. | 8 |
| abstract_inverted_index.important | 181 |
| abstract_inverted_index.including | 61, 188 |
| abstract_inverted_index.increased | 21, 71 |
| abstract_inverted_index.increases | 36 |
| abstract_inverted_index.modulates | 201 |
| abstract_inverted_index.oxidative | 74 |
| abstract_inverted_index.phenotype | 89 |
| abstract_inverted_index.phosphate | 192 |
| abstract_inverted_index.potential | 233 |
| abstract_inverted_index.prevalent | 11 |
| abstract_inverted_index.processes | 151 |
| abstract_inverted_index.restoring | 131 |
| abstract_inverted_index.suggested | 164 |
| abstract_inverted_index.treatment | 143 |
| abstract_inverted_index.unabated. | 123 |
| abstract_inverted_index.Rho-kinase | 124 |
| abstract_inverted_index.TGFβ-SMAD | 207 |
| abstract_inverted_index.apoptosis. | 91 |
| abstract_inverted_index.associated | 211 |
| abstract_inverted_index.beneficial | 167 |
| abstract_inverted_index.deposition | 82 |
| abstract_inverted_index.expression | 102 |
| abstract_inverted_index.inhibitors | 125 |
| abstract_inverted_index.management | 240 |
| abstract_inverted_index.regulation | 189 |
| abstract_inverted_index.remodeling | 84 |
| abstract_inverted_index.resistance | 54 |
| abstract_inverted_index.signaling, | 208 |
| abstract_inverted_index.strategies | 144 |
| abstract_inverted_index.trabecular | 45, 65 |
| abstract_inverted_index.treatments | 96, 114 |
| abstract_inverted_index.underlying | 119, 149 |
| abstract_inverted_index.Schlemm’s | 49 |
| abstract_inverted_index.alleviating | 169 |
| abstract_inverted_index.alterations | 86 |
| abstract_inverted_index.development | 214 |
| abstract_inverted_index.intraocular | 22 |
| abstract_inverted_index.parathyroid | 194 |
| abstract_inverted_index.conventional | 206 |
| abstract_inverted_index.demonstrated | 127 |
| abstract_inverted_index.dysregulated | 78, 154 |
| abstract_inverted_index.inflammation | 175, 222 |
| abstract_inverted_index.irreversible | 6, 32 |
| abstract_inverted_index.pathological | 120 |
| abstract_inverted_index.characterized | 19 |
| abstract_inverted_index.extracellular | 79 |
| abstract_inverted_index.pathogenesis. | 160 |
| abstract_inverted_index.dysregulation, | 60 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5082005077 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I79619799 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.75 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.65780142 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |